Complexity management of genomic DNA by locus specific amplification
View Patent ↗The present invention provides for novel methods and kits for reducing the complexity of a nucleic acid sample to interrogate a collection of target sequences. In one embodiment complexity reduction can be accomplished by extension of a locus specific capture probe followed by amplification of the extended capture probe using common primers. The locus specific capture probes may be attached to a solid support. Multiple DNA sequences may be amplified simultaneously to produce a reduced complexity sample. The invention further provides for analysis of the above sample to interrogate sequences of interest such as polymorphisms. The amplified sample may be hybridized to an array, which may be specifically designed to interrogate the desired fragments for the presence or absence of a polymorphism.
1. A method for genotyping one or more polymorphisms in a nucleic acid sample comprising:
fragmenting the nucleic acid sample to generate fragments;
ligating an adapter to the fragments said adapter comprising a first priming sequence;
hybridizing a collection of capture probes to the fragments, wherein said capture probes comprise in the following order from 5′ to 3′: a second priming sequence that is common to the capture probes in the collection, a tag sequence unique for each species of capture probe, a first target specific sequence, a Type IIs restriction enzyme recognition sequence, and a second target specific sequence wherein the Type IIs restriction enzyme recognition sequence is positioned so that the enzyme will cut on the 5′ side of a polymorphic base;
extending said capture probes to generate extended capture probes in a first extension reaction;
amplifying the extended capture probes with primers to said first and second priming sequences;
digesting the amplified product with a Type IIs restriction enzyme to generate amplified product fragments;
extending the amplified product fragments in at least one second extension reaction;
hybridizing each second extension reaction to an array comprising tag probes that hybridize to the tag sequences in the capture probes; and
analyzing the hybridization pattern on each of the arrays to determine the genotype of one or more polymorphisms in the nucleic acid sample.
2. The method of claim 1 wherein in each second extension reaction there is at least one species of labeled ddNTP.
3. The method of claim 2 wherein one or more species of ddNTPs is labeled with biotin.
4. The method of claim 2 wherein there are four separate second extension reactions wherein each second extension reaction contains a different species of labeled ddNTP and the extension reaction products from each second extension reaction are hybridized to a different array.
5. The method of claim 2 wherein there are two separate second extension reactions wherein two differentially labeled ddNTPs are present in each second extension reaction and the second extension reaction products are hybridized to a different array.
6. The method of claim 2 wherein there is one second extension reaction wherein four differentially labeled ddNTPs are present in the second extension reaction and the extension reaction products arc hybridized to a single array.
7. The method of claim 2 wherein said capture probes are attached to a solid support.
8. The method of claim 7 wherein said capture probes are attached to the solid support through a covalent interaction.
9. The method of claim 7 wherein said capture probes are attached to said solid support by hybridization to a collection of tag probes that are attached to said solid support.
10. The method of claim 7 wherein each species of capture probe is attached to said solid support in a discrete location.
11. The method of claim 7 wherein said capture probes are synthesized on a solid support in a 5′ to 3′ direction.
12. The method of claim 1 wherein one of the primers to said first and second priming sequences is resistant to nuclease digestion and each second extension reaction is digested with a 5′ to 3′ nuclease activity prior to hybridization to an array.
13. The method of claim 12 wherein the nuclease resistant primer comprises phosphorothioate linkages.
14. The method of claim 12 wherein said nuclease is T1 Gene 6 Exonuclease.
15. The method of claim 1 wherein prior to amplification, the extended capture probes are enriched in the sample to be amplified, wherein the method of enrichment comprises depletion of non-extended products or positive selection of extended products.
16. The method of claim 1 wherein labeled nucleotides are incorporated into the extended capture probes and extended capture probes are isolated by affinity chromatography.
17. The method of claim 16 wherein said labeled nucleotides are labeled with biotin, wherein avidin, streptavidin or an anti-biotin antibody is used to isolate extended capture probes.
18. The method of claim 1 wherein prior to amplification, the extended capture probes are circularized and uncircularized nucleic acid in the sample is digested.
19. The method of claim 18 wherein extended capture probes are circularized by a method comprising:
hybridizing an oligonucleotide splint to the extended capture probes, wherein the oligonucleotide splint is complementary to the first and second priming sequences, thereby juxtaposing the 5′ and 3′ ends of extended capture probes; and
ligating the ends of the extended capture probes to form circular extended capture probes.
20. The method of claim 18 wherein the uncircularized nucleic acid remaining in the sample is digested with a nuclease.
21. The method of claim 20 wherein the nuclease is Exonuclease III.
22. The method of claim 1 wherein the nucleic acid sample is fragmented by digestion with one or more restriction enzymes.
23. The method of claim 1 wherein there are 100 to 1500 different target sequences in the collection of target sequences.
24. The method of claim 1 wherein there are 1,000 to 5,000 different target sequences in the collection of target sequences.
25. The method of claim 1 wherein there are 2,000 to 10,000 different target sequences in the collection of target sequences.
26. The method of claim 1 wherein there are 10,000 to 1,000,000 different target sequences in the collection of target sequences.
27. A method for screening for sequence variations in a population of individuals comprising:
providing a nucleic acid sample from each individual;
determining the genotype of one or more polymorphisms in each sample according to the method of claim 1 ; and
comparing the genotypes from the samples to determine the presence or absence of sequence variation in the population of individuals.